Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan Adolfsson

Showing results (101-110 of 168) with videos related to

Pageof 17
Sort By:
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
Plos One|August 24, 2017
Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort studyDuangjai Lexomboon, Pär Karlsson, Jan Adolfsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Incidence and prognosis of synchronous and metachronous bilateral breast cancerMikael Hartman, Kamila Czene, Marie Reilly, et al.
Cancer Causes & Control : CCC|January 9, 2013
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in SwedenSandra Eloranta, Jan Adolfsson, Paul C Lambert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2017
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European dataMagdalena Lycken, Linda Drevin, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|May 15, 2003
Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genesTakashi Wada, Petra Berggren, Gunnar Steineck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristicsEdoardo Colzani, Annelie Liljegren, Anna L V Johansson, et al.
Prostate Cancer and Prostatic Diseases|March 4, 2020
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control studyKerri Beckmann, Hans Garmo, Bertil Lindahl, et al.
BMJ Open|March 18, 2018
Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort studyDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Epidemiology and statistical methods in prediction of patient outcomeDavid G Bostwick, Jan Adolfsson, Harry B Burke, et al.
Pageof 17

Showing results (101-110 of 168) with videos related to

Sort By:
Pageof 17
European Journal of Cancer (Oxford, England : 1990)|August 20, 2011
Differences according to socioeconomic status in the management and mortality in men with high risk prostate cancerAnders Berglund, Hans Garmo, David Robinson, et al.
Plos One|August 24, 2017
Consumption and direct costs of dental care for patients with head and neck cancer: A 16-year cohort studyDuangjai Lexomboon, Pär Karlsson, Jan Adolfsson, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 20, 2007
Incidence and prognosis of synchronous and metachronous bilateral breast cancerMikael Hartman, Kamila Czene, Marie Reilly, et al.
Cancer Causes & Control : CCC|January 9, 2013
How can we make cancer survival statistics more useful for patients and clinicians: an illustration using localized prostate cancer in SwedenSandra Eloranta, Jan Adolfsson, Paul C Lambert, et al.
European Journal of Cancer (Oxford, England : 1990)|December 8, 2017
The use of palliative medications before death from prostate cancer: Swedish population-based study with a comparative overview of European dataMagdalena Lycken, Linda Drevin, Hans Garmo, et al.
Scandinavian Journal of Urology and Nephrology|May 15, 2003
Bladder neoplasms--regions at chromosome 9 with putative tumour suppressor genesTakashi Wada, Petra Berggren, Gunnar Steineck, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 14, 2011
Prognosis of patients with breast cancer: causes of death and effects of time since diagnosis, age, and tumor characteristicsEdoardo Colzani, Annelie Liljegren, Anna L V Johansson, et al.
Prostate Cancer and Prostatic Diseases|March 4, 2020
Spironolactone use is associated with lower prostate cancer risk: a population-wide case-control studyKerri Beckmann, Hans Garmo, Bertil Lindahl, et al.
BMJ Open|March 18, 2018
Does a prostate cancer diagnosis affect management of pre-existing diabetes? Results from PCBaSe Sweden: a nationwide cohort studyDanielle Crawley, Hans Garmo, Sarah Rudman, et al.
Scandinavian Journal of Urology and Nephrology. Supplementum|July 16, 2005
Epidemiology and statistical methods in prediction of patient outcomeDavid G Bostwick, Jan Adolfsson, Harry B Burke, et al.
Pageof 17